Paul Hastings represented Seelos Therapeutics, Inc. in the offering, and Sichenzia Ross Ference Carmel represented Titan Partners Group. Seelos Theraputics Inc. (NASDAQ: SEEL) announced a $5.55 million public...
This content is for Standard 1 Year members only. LoginJoin Now